22157.jpg
US Transdermal Patch Market Opportunity & Clinical Trials Insight 2028: Smart Patches Which Transmit Live Patient Data Presents Lucrative Opportunities
14 oct. 2022 04h13 HE | Research and Markets
Dublin, Oct. 14, 2022 (GLOBE NEWSWIRE) -- The "US Transdermal Patch Market Opportunity & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. Transdermal...
22157.jpg
Global Transdermal Patch Market, Dosage, Price & Clinical Trials Insight to 2028: Comprehensive Insight on 60 Transdermal Patch Available Commercially
23 févr. 2022 07h43 HE | Research and Markets
Dublin, Feb. 23, 2022 (GLOBE NEWSWIRE) -- The "Global Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. The...
Agile_Logo-color on white.jpg
Agile Therapeutics Announces Addition of Twirla® to a Preferred Drug Position on Medi-Cal Formulary
04 oct. 2021 08h02 HE | Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced today that the California Medicaid Program, Medi-Cal, has placed...
Agile_Logo-color on white.jpg
Agile Therapeutics Partners with Carli Lloyd, U.S. Women’s Soccer Star and Four-Time Olympian, to Bring Awareness to Women’s Health Topics
28 sept. 2021 08h01 HE | Agile Therapeutics, Inc.
PRINCETON, N.J., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced today a partnership with U.S. Women’s Soccer legend, Carli Lloyd....
Agile_Logo-color on white.jpg
Agile Therapeutics Partners with Telehealth Service, Pandia Health, to Increase Women’s Access to Twirla® (levonorgestrel and ethinyl estradiol) transdermal system
20 août 2021 07h30 HE | Agile Therapeutics, Inc.
Pandia Health is a doctor founded and led telehealth company, offering online prescriptions and free delivery designed to make it easier for women to access birth control options that meet their...
Agile_Logo-color on white.jpg
Agile Therapeutics Announces Presentation of Safety and Efficacy Data of Twirla® (Levonorgestrel and Ethinyl Estradiol) Transdermal System in Women of Differing BMI Categories at ACOG Annual Meeting
30 avr. 2021 11h01 HE | Agile Therapeutics, Inc.
PRINCETON, N.J., April 30, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that a post hoc analysis of the Phase 3 SECURE Trial...
22157.jpg
United States Transdermal Patch Market Report 2021-2026: Dosage, Price & Clinical Trials Insights - Technology Innovation and Increasing Acceptability Toward Patch Drug Delivery Methodology
30 mars 2021 06h28 HE | Research and Markets
Dublin, March 30, 2021 (GLOBE NEWSWIRE) -- The "US Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering. US...
Agile_Logo-color on white.jpg
Agile Therapeutics Reports Fourth Quarter & Full Year 2020 Financial Results; Expands Loan Facility With Perceptive Advisors
01 mars 2021 16h05 HE | Agile Therapeutics, Inc.
Perceptive Advisors Increases Credit Facility to $45 million, with $25 million potentially available Achieved Gross Revenue Target In Fourth Quarter 2020, Reflecting Initial Stocking of Twirla®...
Agile_Logo-color on white.jpg
Agile Therapeutics Inc. Hosts First Analyst Day Focused on Previewing its Corporate Vision and Commercial Strategy
10 oct. 2017 18h38 HE | Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 10, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s healthcare company, today hosted the Company’s first analyst day in New York City to showcase its...
Agile_Logo-color on white.jpg
Agile Therapeutics to Host First Analyst Day on October 10, 2017
02 oct. 2017 07h30 HE | Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 02, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's healthcare company, today announced that the Company will host its first Analyst Day on Tuesday,...